Wall Street Journal: Business: Management

John Milligan, Gilead’s new CEO, will face many challenges, including pressures over competition and pricing for the company’s hepatitis C pills. Gilead sales have risen nearly 3½ times to $32.2 billion last year.

New York law firm Cravath, Swaine & Moore is raising its base pay for starting lawyers by 12.5%, the first increase in nearly a decade and a move likely to trigger a wave of similar hikes throughout the legal industry.

Former pharmaceutical executive Martin Shkreli pleaded not guilty Monday to a new conspiracy charge filed by Brooklyn federal prosecutors.

Lawyers for Philippe Dauman and George Abrams said the purported ratification of their removal from Sumner Redstone’s trust by a majority of trustees is “meaningless.”

Tony Fadell, chief executive of Alphabet’s home-automation firm Nest, is leaving the company he co-founded six years ago amid reports that he was losing support of employees.

Struggling commodities trader Noble Group said its chairman would retire and it is planning a rights issue, the latest in a series of attempts by the company to shore up its weak financial position.

Tribune Publishing said shareholders voted to re-elect the company’s board nominees Thursday as the newspaper owner also announced plans to change its name.

Medivation Inc.’s shareholders as of close of business Wednesday will be able to vote on Sanofi SA’s proposal to replace the oncology drugmaker’s board.

Silicon Valley entrepreneur Peter Thiel will remain a director of Facebook Inc. despite his providing the funding for lawsuits against Gawker Media, Facebook Chief Operating Officer Sheryl Sandberg said Wednesday.

One of Sumner Redstone’s grandchildren has gone on the offensive against his daughter Shari, accusing her of manipulating the mogul and turning him against Viacom’s board.